ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BeyondSpring Announces U.S. FDA Acceptance And Priority Review Of New Drug Application For Plinabulin And G-CSF Combination For The Prevention Of Chemotherapy-Induced Neutropenia (CIN)
June 21, 2021BeyondSpring Inc. today announced that the FDA has accepted for filing, and with Priority Review, the Company’s NDA seeking approval for use of plinabulin in combination with granulocyte colony-stimulating factor -
BeyondSpring Granted Patent for Plinabulin
May 18, 2020BeyondSpring announced the United States Patent and Trademark Office (USPTO) has granted the Company a new patent. -
BeyondSpring Files for Patent Protection for Viral Infections Treatment
March 16, 2020BeyondSpring announced the submission of a provisional U.S. patent application for its pipeline asset BPI-002, for methods of treating viral infections, including COVID-19 ...
Pharma Sources Insight January 2025
